Home » Topics » Conferences

Conferences
RSS

Lilly prepares raloxifene analogs that reverse MRP-mediated resistance

May 12, 1997

Retinoid-like compounds that induce apoptosis in cancer cells

May 12, 1997

Glycan-conjugated 5-FU for the treatment of hepatocellular cancer/metastases

May 12, 1997

Taiho discovers potent and selective cdc25PTP inhibitors

May 12, 1997

Parke-Davis develops new c-src TK inhibitors

May 12, 1997

RPR selects farnesyltransferase inhibitor for in vivo evaluation

May 12, 1997

Schering-Plough evaluates novel farnesyltransferase inhibitor

May 12, 1997

TAS-103 shows antitumor activity against orthotopically implanted human cancers

May 12, 1997

In vivo efficacy and pharmacokinetic profile of XR-9051

May 12, 1997

Positive preclinical results with CB-1267 in combination with 9-cis-RA for prostate cancer

May 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...